Obsidian Therapeutics, Inc. OBX

Set alert

Price alert · OBX

All alert types
14.75 USD +0.32 +2.22%

As of Nov 3, 10:39 AM ET

Bid
14.66 × 1
Ask
14.94 × 1
14.00 Day range 14.97
11.52 52-week range 49.97
YTD
-15.71%
1 year
-15.71%
Open
14.23
Prev close
14.43
Mkt cap
911.15M
Vol
92.70K
Avg vol
395.13K
EPS
-1.63
P/E
0.00
Div yield
0.00%
More statistics
Low
14.00
High
14.97
Forward P/E
-7.98
Beta
2.60
Short ratio
0.69
Inst. own
27.36%
Dividend
0.00
Ex-div date
Earnings
Mar 31, 2025
50-d avg
19.99
200-d avg
19.99
1y target
39.00

1D chart

Chart tools
Interval

Signals (33)
NameTimeAgo
MACD: Buy Signal2:31 PM20 hours ago
RSI: Oversold2:23 PM20 hours ago
SMA: Bearish2:00 PM20 hours ago
MACD: Sell Signal1:47 PM20 hours ago
MACD: Buy Signal1:36 PM21 hours ago
RSI: Overbought1:36 PM21 hours ago
MACD: Sell Signal1:20 PM21 hours ago
RSI: Overbought1:06 PM21 hours ago
RSI: Overbought12:59 PM21 hours ago
MACD: Buy Signal12:53 PM21 hours ago
RSI: Overbought12:53 PM21 hours ago
MACD: Sell Signal12:37 PM22 hours ago
SMA: Bullish12:18 PM22 hours ago
SMA: Bearish12:13 PM22 hours ago
SMA: Bullish12:09 PM22 hours ago
MACD: Buy Signal12:04 PM22 hours ago
MACD: Sell Signal11:54 AM22 hours ago
RSI: Oversold11:51 AM22 hours ago
MACD: Buy Signal11:38 AM23 hours ago
SMA: Bearish11:20 AM23 hours ago

Newest 20 of 33.

Held by funds

13 US ETFs and mutual funds hold OBX · largest positions

Funds holding OBX, by value held
FundValue heldWeight in fund
VTI $25.72M0.00%
VXF $6.98M0.01%
SCHA $3.58M0.02%
FSMAX $2.82M0.01%
GCSH $1.98M0.04%
GISC $1.31M0.09%
FSKAX $1.19M0.00%
ITOT $915.97K0.00%
FNCMX $473.67K0.00%
VBINX $432.71K0.00%
SCHB $419.97K0.00%
VITPX $385.52K0.00%
TNXT $9.39K0.05%

Ownership

Held by insiders 0.81%
Held by institutions 27.36%
Float held by institutions 27.58%
Institutions 5

Top institutional holders

No holders on record

Top mutual fund holders

No holders on record

OBX insiders
InsiderRelationLatest transactionDateShares held
CHANG NANCY TDirector and Beneficial Owner of more than 10% of a Class of SecurityConversion of Exercise of derivative securityMay 14, 20260
EMERALD BIOVENTURES LLCBeneficial Owner of more than 10% of a Class of SecurityConversion of Exercise of derivative securityMay 14, 20260
FRIEDMAN MICHAEL RDirectorConversion of Exercise of derivative securityMay 14, 20260
SORENSEN J. MELChief Executive OfficerSaleNov 19, 2025195,029
SORENSEN MELINDAChief Executive OfficerSaleNov 19, 2025195,029